New cancer therapy comes of age, cost a 'toxic' side effect

New cancer therapy comes of age, cost a 'toxic' side effect

By Ben Hirschler MADRID (Reuters) - A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects -- but their high cost is a growing concern. Drugs that help the body's own immune cells fight tumors are expected to be used in multi-drug cocktails, pushing the price of therapies costing more than $100,000 a year even higher. At the same time, other expensive medicines are being combined to produce impressive results fighting diseases including breast and skin cancer. ...

Steroid-fattened cows spark health fears in Bangladesh on Eid

Dhaka (AFP) - Bangladesh sent medical teams on Tuesday to check millions of cows set for slaughter due to fears they have been pumped with banned steroids for fattening ahead of the Eid holiday.

New cancer therapy comes of age, cost a 'toxic' side effect

By Ben Hirschler MADRID (Reuters) - A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects -- but their high cost is a growing concern. Drugs that help the body's own immune cells fight tumors are expected to be used in multi-drug cocktails, pushing the price of therapies costing more than $100,000 a year even higher. At the same time, other expensive medicines are being combined to produce impressive results fighting diseases including breast and skin cancer. ...

Children of Ebola dead shunned by families: UNICEF

Dakar (AFP) - Thousands of children who have lost parents to the west African Ebola epidemic risk are being shunned by frightened and suspicious relatives, the UN children's fund said on Tuesday.

NFL TV ratings on the rise despite domestic violence fumble

By Eric Kelsey LOS ANGELES (Reuters) - Americans are tuning into NFL football in greater numbers than last year, according to early season viewership figures, signaling the league's fumbled handling of domestic violence cases has not dented its overall popularity. Through the first three weeks of the season, audiences watching nationally televised primetime broadcasts have risen and nearly all networks have seen an uptick in viewership so far this season. ...

Families wait in agony for word on Ebola patients

MONROVIA, Liberia (AP) — First the ring tone echoed outside the barbed-wire-topped walls of the Ebola clinic. Then came the wails of grief, as news spread that 31-year-old Rose Johnson was dead just days after she was brought here unconscious by relatives.

India's Modi must resist U.S. pressure on drug patents: MSF

By Nita Bhalla NEW DELHI (Thomson Reuters Foundation) - Indian Prime Minister Narendra Modi must not give in to U.S. pressure to change intellectual property laws which allow India to produce generic medicines poor people can afford, the medical charity Doctors Without Borders (MSF) said. Modi, who is visiting the United States to bolster trade and investment ties, has been meeting senior Congressmen and business leaders. He met President Barack Obama at a White House dinner on Monday and the two will hold further talks on Tuesday. MSF said U.S. ...

US Ebola labs, parts for clinic arrive in Liberia

MONROVIA, Liberia (AP) — U.S. mobile Ebola labs should be up and running in Liberia this week, and American troops have broken ground for a field hospital, as the international community races to increase the ability to care for the spiraling number of people infected with the dreaded disease.

Johnson & Johnson buying Alios for $1.75B

NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson is buying the biopharmaceutical company Alios BioPharma Inc. for about $1.75 billion.

France uses tax to put pressure on hepatitis C drug prices

By Natalie Huet PARIS (Reuters) - France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices. The Socialist government said it had designed a "progressive contribution scheme" ensuring all patients can access new and more effective treatments against the liver-destroying virus, while limiting the burden of these drugs on state finances. ...

You are reading an article about New cancer therapy comes of age, cost a 'toxic' side effect and you can find this article in url https://we-care-you.blogspot.com/2014/09/new-cancer-therapy-comes-of-age-cost.html,You can copy paste and use the article New cancer therapy comes of age, cost a 'toxic' side effect , may this is very interesting for you and others ,but don't forget to take this link New cancer therapy comes of age, cost a 'toxic' side effect for article source, Thanks.